SLC2A1 and breast carcinoma: For example, miR-122 is highly secreted by tumor cells and promotes metastasis by adapting to the metabolic environment in the pre-metastatic niche, while down-regulation of PKM2 and glucose transporter type 1 (GLUT1) inhibits glucose metabolism in breast cancer cells [17].